Biocon Arm Gets Health Canada Nod for Micafungin Injection to Treat Serious Fungal Infections MD Bureau13 May 2026 8:38 PM ISTNew Delhi: Biocon Ltd on Monday said its arm Biocon Pharma Ltd has received approval from Health Canada for micafungin for injection indicated for...
Kiran Mazumdar Shaw Picks Niece Claire Mazumdar to Steer Biocon's Next Phase Parthika Patel5 May 2026 8:44 PM ISTClaire Mazumdar, a 37-year-old biotechnology professional currently serves as founder and CEO of Bicara Therapeutics.
Biocon Receives 5 USFDA Observations at Bengaluru Biosimilars Site Parthika Patel30 April 2026 7:52 PM ISTNew Delhi: Biocon Limited has announced that the United States Food and Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at...
Biocon Secures Health Canada Nod for Denosumab Biosimilars Bosaya, Vevzuo sheeba farhat21 April 2026 11:45 PM ISTBengaluru: Biocon Limited has received a Notice of Compliance (NOC) from Health Canada for its denosumab biosimilars Bosaya and Vevzuo, marking a...
Biocon Launches Denosumab Biosimilars Bosaya, Aukelso in US Parthika Patel9 April 2026 8:33 PM ISTNew Delhi: Biocon Limited has announced the commercial launch of its denosumab biosimilars, Bosaya and Aukelso, in the United States, marking a...
Biocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business Integration sheeba farhat28 March 2026 8:18 PM ISTBengaluru: Biocon Limited today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1,...
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for Diabetes Parthika Patel13 March 2026 11:28 PM ISTNew Delhi: Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for...
Biocon Gets USFDA Nod for gSaxenda, Enters US GLP-1 Weight Loss Market sheeba farhat25 Feb 2026 2:55 PM ISTNew Delhi: Biocon Limited has secured approval from the U.S. Food and Drug Administration (USFDA) for its complex formulation Liraglutide Injection,...
Catalyst for Biosimilars, Innovation: Pharma Majors Applaud Biopharma Shakti Push in Union Budget 2026 sheeba farhat2 Feb 2026 5:31 PM ISTNew Delhi: India's pharmaceutical and biopharmaceutical industry has welcomed the Union Budget 2026, particularly the launch of the Biopharma SHAKTI...
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics Arm Parthika Patel16 Jan 2026 9:16 PM ISTBengaluru: Biocon Limited has successfully concluded a Rs 4,150 crore (approximately USD 460 million) equity fundraise through a Qualified...
Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC sheeba farhat12 Jan 2026 11:15 PM ISTBengaluru: Biocon Limited on Monday said its wholly owned subsidiary, Biocon Pharma Limited, has received approval from the United States Food and...
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs Parthika Patel7 Jan 2026 4:37 PM ISTThese products are among the largest oncology biologics expected to lose exclusivity over the next five years.
